Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Liver Cancer Prognosis: Amazing New Cures
Liver Cancer Prognosis: Amazing New Cures 4

The best treatment for liver tumors depends on several factors. These include the tumor’s type, stage, and the patient’s overall health.

It’s important to understand these factors to find the most effective treatment. Advanced treatments are now available, improving outcomes for patients.

There are various liver cancer treatments available today. Patients can now access new therapies that were not available before.

Key Takeaways

  • The type and stage of the tumor significantly influence the treatment plan.
  • Patient health plays a critical role in determining the best treatment approach.
  • Advanced therapies offer improved outcomes for patients with liver tumors.
  • Access to cutting-edge treatments is now available for patients.
  • Understanding the tumor and patient factors is key to effective treatment.

Understanding Liver Tumors

It’s important to know about liver tumors to get the right treatment. They can be either primary or secondary, each with its own risks and effects. Liver tumors are a big health problem around the world.

Primary vs. Secondary Liver Tumors

Primary liver tumors start in the liver. Hepatocellular carcinoma (HCC) is the most common type. It often happens in people with chronic liver disease or cirrhosis.

Secondary liver tumors come from cancer spreading to the liver from other places. This usually happens with cancers like colorectal, breast, and lung.

Knowing if a tumor is primary or secondary helps doctors decide how to treat it. Primary tumors are treated in the liver. But secondary tumors need treatment for both the original cancer and the liver spots.

Risk Factors and Causes

Many things can increase the chance of getting liver tumors. Chronic hepatitis B or C virus infection is a big risk for HCC. Drinking too much alcohol, aflatoxin exposure, and NAFLD also play a part. Knowing these risks helps prevent and catch tumors early.

With the right treatment, liver tumors can be managed well. This depends on accurate diagnosis and knowing the tumor type and risks.

Diagnosis and Staging of Liver Tumors

SEP 6500 image 2 LIV Hospital
Liver Cancer Prognosis: Amazing New Cures 5

Getting a correct diagnosis and staging is key for treating liver cancer. Doctors use imaging tests, lab tests, and sometimes a biopsy to find out if you have liver cancer and how far it has spread.

Diagnostic Procedures and Tests

There are several ways to find liver tumors. These include:

  • Imaging Tests: CT scans, MRI, and ultrasound show the tumor’s size, where it is, and if it has spread.
  • Laboratory Tests: Blood tests check the liver’s health and look for tumor markers.
  • Biopsy: A biopsy takes a small liver sample for a detailed check to confirm the diagnosis.

These tests are important for understanding the liver tumor and planning treatment.

Staging Systems and Their Importance

Staging systems help figure out how far the cancer has spread. This is key for picking the right treatment. The American Cancer Society says knowing the stage is important for survival rates and treatment choices.

Stage

Description

Typical Treatment Approaches

Early Stage

Tumor is small and localized

Surgical resection, ablation therapies

Intermediate Stage

Tumor is larger or multifocal

Embolization therapies, targeted therapies

Advanced Stage

Tumor has spread to other parts of the body

Systemic therapies, palliative care

Accurate staging is vital for choosing the best treatment and improving patient outcomes.

Factors Influencing Treatment Selection

SEP 6500 image 3 LIV Hospital
Liver Cancer Prognosis: Amazing New Cures 6

Choosing the right treatment for liver cancer depends on several key factors. It’s important to understand these to pick the best treatment plan.

Tumor Characteristics

The size, location, and number of tumors are important. A small tumor in one spot might be treated differently than many large ones spread out.

Liver Function Assessment

How well the liver works is also a big factor. Doctors use tests to check liver function and cirrhosis. If the liver isn’t working well, treatment might need to be adjusted.

Patient’s Overall Health Status

The patient’s overall health matters too. Health issues can affect which treatments are safe. For example, someone with serious health problems might not be able to have surgery.

Factor

Influence on Treatment

Examples

Tumor Characteristics

Determines suitability for localized treatments

Size, location, number of tumors

Liver Function

Affects tolerance to certain treatments

Liver function tests, cirrhosis assessment

Patient’s Health Status

Influences candidacy for aggressive treatments

Presence of comorbidities, physical condition

Surgical Resection: The Gold Standard

For many patients with liver cancer, surgical resection is the top choice. This method removes the tumor, aiming for a cure for some patients.

Candidates for Liver Resection

Not every liver cancer patient can have liver resection. The choice to have surgery depends on several things. These include the tumor’s size and location, how well the liver works, and the patient’s health.

A team of experts looks at these factors to decide the best treatment.

The criteria for choosing patients for liver resection include:

  • Tumor characteristics, such as size and number
  • Liver function, assessed through tests like the Child-Pugh score
  • Presence of cirrhosis or other underlying liver conditions
  • Patient’s performance status and comorbidities

The Surgical Procedure

Liver cancer surgery, or hepatic resection, is a complex process. It needs a skilled team. The surgery removes the liver part with the tumor and some healthy tissue.

Techniques like intraoperative ultrasound help guide the surgery. They confirm the tumor’s location and margins.

Recovery and Outcomes

Recovery from liver resection varies. It depends on the surgery’s extent and the patient’s health. Patients are closely watched in the intensive care unit after surgery. They are then moved to a regular ward as they get better.

Survival rates after liver cancer surgery have improved. Five-year survival rates range from 40% to 70% for selected patients. Survival depends on the cancer’s stage, liver disease, and how well the tumor was removed.

Factor

Influence on Outcome

Tumor Stage

Early-stage tumors have better outcomes

Underlying Liver Disease

Cirrhosis or other conditions can complicate recovery

Completeness of Resection

Complete removal of the tumor is critical for long-term survival

A study shows, “The completeness of surgical resection is a critical determinant of long-term survival in patients with liver cancer.”

“Surgical resection offers a chance for cure in early-stage liver cancer. Early detection and treatment are key.”

— Expert in Hepatobiliary Surgery

Liver Transplantation for Tumor Treatment

Liver transplantation is a treatment that can cure some liver cancer patients. It involves swapping a sick liver with a healthy one from a donor. Doctors decide if a patient is a good candidate based on the tumor size and overall health.

Selection Criteria for Transplantation

Choosing who gets a liver transplant is very careful. Patients need to have a small tumor or a few small tumors without spreading. The Milan Criteria help doctors pick the best candidates.

Key Selection Criteria:

  • Single tumor ≤ 5 cm
  • Up to 3 tumors, each ≤ 3 cm
  • No vascular invasion
  • No extrahepatic spread

The Transplantation Process

The liver transplant process is detailed and involves many steps. First, patients are checked to see if they’re a good match. Then, they wait for a liver to become available. The surgery removes the old liver and puts in the new one.

Post-Transplant Survival Rates

Thanks to better surgery and medicine, survival rates have gone up. Patients who fit the Milan Criteria have a 70% chance of living 5 years after the transplant.

Criteria

5-Year Survival Rate

Within Milan Criteria

70%

Beyond Milan Criteria

50%

A study found that liver transplant is a lifesaver for some cancer patients. It gives them a chance to live longer.

“The outcomes of liver transplantation for liver cancer are highly dependent on careful patient selection and post-transplant care.”

Ablative Therapies for Localized Tumors

Localized liver tumors can be treated with ablative therapies. These methods destroy cancer cells without surgery. They are great for patients who can’t have surgery because of where their tumors are or their health.

Ablative therapies target and kill tumor cells, keeping healthy tissue safe. This method causes less damage to the liver and cuts down on recovery time. It’s less invasive than surgery.

Radiofrequency and Microwave Ablation

Radiofrequency ablation (RFA) and microwave ablation (MVA) are common treatments. They use a needle probe inserted into the tumor under imaging.

  • Radiofrequency Ablation (RFA): RFA heats the tumor with electrical energy, killing cancer cells. It works for tumors up to 3 cm.
  • Microwave Ablation (MVA): MVA uses microwave energy to heat and kill tumor cells. It’s better for larger tumors than RFA.

Histotripsy: The Emerging Non-Invasive Option

Histotripsy is a new, non-invasive therapy. It uses focused ultrasound waves to destroy tumor cells. It doesn’t need needles or heat, which might reduce side effects and recovery time.

Histotripsy is being tested in clinical trials. It shows promise for treating liver tumors. Its non-invasive nature makes it appealing for those avoiding invasive treatments.

The growth of ablative therapies like RFA, MVA, and histotripsy is opening up new treatment paths. They offer hope for better outcomes and quality of life for patients with localized liver tumors.

Embolization Treatments for Inoperable Tumors

Embolization therapies are key for treating liver tumors that can’t be removed by surgery. These methods are non-invasive. They aim to shrink tumors and ease symptoms by cutting off their blood supply.

There are several embolization techniques for treating inoperable liver tumors. Each has its own benefits and uses.

Transarterial Chemoembolization (TACE)

Transarterial Chemoembolization (TACE) is a common method for treating liver tumors. It involves delivering chemotherapy drugs directly to the tumor through the hepatic artery. Then, it blocks the blood supply to the tumor.

This approach makes chemotherapy more effective and reduces side effects. It’s great for patients with tumors that can’t be removed.

  • TACE is very effective for patients with unresectable liver tumors.
  • The procedure can be repeated as needed to control the tumor.
  • Common side effects include post-embolization syndrome, which usually goes away on its own.

Radioembolization with Y-90

Radioembolization with Yttrium-90 (Y-90) delivers radioactive microspheres directly to the tumor. The radiation from the Y-90 microspheres kills tumor cells while protecting healthy tissue.

  1. Radioembolization is often used for patients with advanced liver cancer.
  2. The procedure can be done on an outpatient basis, shortening hospital stays.
  3. Potential side effects include fatigue and abdominal pain, which are usually manageable.

Both TACE and radioembolization with Y-90 are valuable for patients with inoperable liver tumors. They improve survival rates and quality of life.

Radiation Therapy Approaches

Radiation therapy is a key treatment for liver cancer. It uses high-energy particles or waves to kill or damage cancer cells. This stops them from growing and dividing.

External Beam Radiation Therapy

External Beam Radiation Therapy (EBRT) is a non-invasive method. It sends radiation from outside the body to the tumor. This is good for tumors that can’t be removed or for those who can’t have surgery.

EBRT is precise, aiming high doses at the tumor and sparing healthy tissues. New imaging tech has made it even more accurate. Doctors can now tailor treatments based on the tumor’s details.

Stereotactic Body Radiation Therapy

Stereotactic Body Radiation Therapy (SBRT) is a special EBRT. It gives precise, high doses to small, well-defined tumors. SBRT is fast, often finishing in just a few sessions.

SBRT’s accuracy comes from advanced imaging and keeping the patient steady. It’s great for small, localized liver tumors. It’s a good option for those who can’t have other treatments.

Targeted Systemic Therapies

Targeted systemic therapies are key in fighting liver cancer. They aim at specific molecules or pathways in cancer cells. This makes them more precise than traditional chemotherapy.

These therapies have greatly helped patients with advanced liver cancer. They focus on specific targets to slow cancer growth. This helps protect healthy cells too.

Tyrosine Kinase Inhibitors (TKIs)

Tyrosine Kinase Inhibitors (TKIs) are a promising treatment for liver cancer. They block tyrosine kinases, enzymes that control cell growth. In liver cancer, these enzymes are too active, helping tumors grow.

Sorafenib and lenvatinib are TKIs approved for advanced liver cancer. Studies show they can improve survival and slow disease progression.

Immune Checkpoint Inhibitors (ICIs)

Immune Checkpoint Inhibitors (ICIs) are another vital therapy for liver cancer. They boost the immune system to fight cancer cells better. In liver cancer, the immune system is often weak, letting cancer cells grow unchecked.

Nivolumab and pembrolizumab are ICIs being studied for liver cancer. Early results are encouraging, giving hope to those with advanced disease.

The growth of targeted therapies, like TKIs and ICIs, is a big step forward in liver cancer treatment. Ongoing research aims to find more targets and improve treatment outcomes.

Liver Cancer Prognosis: Survival Rates by Stage and Treatment

Liver cancer’s outlook changes a lot based on when it’s found and how it’s treated. Knowing what affects survival rates is key for both patients and doctors.

The outlook for liver cancer patients depends on the disease’s stage, treatment success, and overall health. Early-stage liver cancer has a better chance of recovery than later stages.

Regional and Metastatic Disease Outcomes

Patients with regional liver cancer face a tougher road. This is because the disease has spread to nearby tissues or lymph nodes. Their five-year survival rate is much lower than those with localized disease.

When liver cancer spreads to distant parts of the body, the outlook is usually bleak. Treatment for metastatic liver cancer focuses on improving life quality, not curing it.

Prognostic Factors Affecting Survival

Several factors influence liver cancer survival. These include the disease’s stage, liver function, and any underlying health issues.

Treatment success also greatly impacts survival rates. Patients who get timely, effective treatment often do better than those who don’t.

Doctors can better predict treatment success by understanding these factors. This helps them give patients clear survival rate expectations.

Supportive Care and Quality of Life

Supportive care is key in managing liver cancer. It helps ease symptoms and side effects of treatment. This care is vital for improving patients’ lives while they undergo treatment.

Good supportive care comes from a team effort. It includes managing side effects and giving nutritional support. This all-around care helps patients deal with their treatment’s challenges.

Managing Treatment Side Effects

It’s important to manage liver cancer treatment side effects. These can be fatigue, nausea, and pain. There are ways to handle these issues through supportive care.

  • Medications to ease symptoms like nausea and pain
  • Palliative care to boost overall well-being
  • Psychological support for anxiety and depression

By managing these side effects well, patients can handle their treatment better. They can also stay independent.

Nutritional Support for Liver Cancer Patients

Nutritional support is a big part of caring for liver cancer patients. Good nutrition helps patients get through treatment and recover well.

Nutritional strategies include:

  1. Dietary advice to get enough calories and protein
  2. Nutritional supplements for health support
  3. Drinking enough water to avoid dehydration

Healthcare providers focus on these supportive care areas. This helps improve liver cancer patients’ quality of life. It makes their treatment journey easier.

Emerging Treatments and Clinical Trials

Liver cancer treatment is changing fast thanks to new clinical trials and therapies. Scientists are working hard to find better ways to help patients live longer.

Novel Targeted Therapies in Development

New treatments aim to hit cancer cells hard but spare healthy ones. Tyrosine kinase inhibitors and immune checkpoint inhibitors are showing great promise in trials.

This is a big leap for liver cancer treatment. It means patients have more choices and might see better results.

Therapy Type

Description

Current Status

Tyrosine Kinase Inhibitors

Target specific enzymes involved in cancer cell growth

In clinical trials

Immune Checkpoint Inhibitors

Enhance the body’s immune response against cancer cells

In clinical trials

Accessing Clinical Trials

For patients with liver cancer, clinical trials might be a good choice. If standard treatments have failed, talking to a doctor about trials is a smart move.

Trials offer new treatments and help doctors learn more. They’re key to finding better treatments for the future.

Conclusion

Liver cancer treatment has grown a lot, giving patients many choices. The best treatment depends on the cancer type, stage, and the patient’s health.

The Surveillance, Epidemiology, and End Results (SEER) program reports on liver cancer. In 2025, it’s expected to see 42,240 new cases and 30,090 deaths. The 5-year survival rate is 22.0%. For cancers caught early, the survival rate jumps to 37.6%.

Knowing how likely you are to beat liver cancer is key. Treatments include surgery, liver transplant, and more. Each has its own good and bad sides. Often, the best plan mixes different treatments.

In short, treating liver cancer is complex. By learning about the options and their effects, patients can choose wisely.

FAQ

What are the primary types of liver cancer?

Liver cancer mainly includes hepatocellular carcinoma (HCC), cholangiocarcinoma, and hepatoblastoma. HCC is the most common, linked to liver disease.

How is liver cancer diagnosed?

Doctors use imaging tests like CT, MRI, and ultrasound to find liver cancer. They also do biopsies and check liver function and tumor markers.

What are the stages of liver cancer?

It looks at tumor size, number, and spread. It also considers liver function and how well the patient can do daily activities.

What is the best treatment for early-stage liver cancer?

Early-stage liver cancer might be treated with surgery, liver transplant, or ablative therapies. The choice depends on the tumor and the patient’s health.

Can liver cancer be cured?

Yes, some liver cancers can be cured. This is more likely if caught early and treated with surgery or transplant.

What is the survival rate for liver cancer patients?

Survival rates vary by stage. Early-stage patients have a better chance than those with advanced disease.

What are the treatment options for advanced liver cancer?

Advanced liver cancer can be treated with targeted therapies and immune therapies. Embolization and radiation therapy are also options.

How does liver function affect treatment selection?

Liver function is key in choosing treatments. Poor liver function might rule out surgery or transplant.

What is the role of supportive care in liver cancer treatment?

Supportive care helps manage side effects and improves quality of life. It includes nutrition support and more.

Are there any emerging treatments for liver cancer?

Yes, new treatments like targeted and immunotherapies are being tested in trials.

How can patients access clinical trials for liver cancer?

Patients can find trials by talking to their doctor or searching online. Liver cancer research groups can also help.

What is the prognosis for patients with metastatic liver cancer?

Metastatic liver cancer has a poor prognosis. Yet, treatments like systemic therapies can help manage symptoms and improve life quality.

Can cirrhosis of the liver be treated?

Cirrhosis is chronic, but treatments can manage complications and slow disease. This improves quality of life.

What is the best medicine for liver disease?

The best medicine varies by disease cause and severity. It may include medications for symptoms, slowing disease, or treating underlying conditions.


References

https://pmc.ncbi.nlm.nih.gov/articles/PMC10776289

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 42 01